Literature DB >> 9892727

Sequence analysis of the rat Brca1 homolog and its promoter region.

L M Bennett1, H A Brownlee, S Hagavik, R W Wiseman.   

Abstract

Since the identification of the human breast and ovarian cancer gene, BRCA1, a large spectrum of germline mutations has been characterized that predispose women to developing these diseases. We have determined the complete coding sequence for the rat BRCA1 homolog and compared it with those of the mouse, dog, and human to help identify the important functional domains of the BRCA1 protein. The overall rat Brcal amino acid identity compared with the predicted mouse, dog, and human gene products is 81%, 69%, and 58%, respectively. In spite of this low overall homology, the amino terminal RING finger domain and one of two nuclear localization signals are highly conserved among these species. In addition, two BRCT domains at the carboxy terminus and a highly acidic region are relatively well conserved. We have also identified several putative regulatory elements through comparison of the bidirectional BRCA1 promoter regions among the rat, mouse, and human genes. These include motifs for CCAAT and G/C boxes, as well as potential SP1, CREB, and NFkB transcription factor binding sites. Finally, analysis of splice variants from rat mammary gland, ovary, testis, spleen, and liver tissues revealed that, while alternative transcripts are detectable, full-length transcripts are the predominant steady-state form.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892727     DOI: 10.1007/s003359900935

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  7 in total

1.  BRCA1 variants in a family study of African-American and Latina women.

Authors:  Roberta McKean-Cowdin; Heather Spencer Feigelson; Lucy Y Xia; Celeste Leigh Pearce; Duncan C Thomas; Daniel O Stram; Brian E Henderson
Journal:  Hum Genet       Date:  2005-02-23       Impact factor: 4.132

2.  Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

Authors:  J Vallon-Christersson; C Cayanan; K Haraldsson; N Loman; J T Bergthorsson; K Brøndum-Nielsen; A M Gerdes; P Møller; U Kristoffersson; H Olsson; A Borg; A N Monteiro
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

3.  Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.

Authors:  F Hayes; C Cayanan; D Barillà; A N Monteiro
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

4.  Characterization of Arabidopsis thaliana ortholog of the human breast cancer susceptibility gene 1: AtBRCA1, strongly induced by gamma rays.

Authors:  S Lafarge; M-H Montané
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

5.  Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma.

Authors:  Gustavo Baldassarre; Sabrina Battista; Barbara Belletti; Sanjay Thakur; Francesca Pentimalli; Francesco Trapasso; Monica Fedele; Giovanna Pierantoni; Carlo M Croce; Alfredo Fusco
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.

Authors:  Donato F Romagnolo; Andreas J Papoutsis; Christina Laukaitis; Ornella I Selmin
Journal:  BMC Cancer       Date:  2015-12-29       Impact factor: 4.430

7.  Relationship between three novel SNPs of BRCA1 and canine mammary tumors.

Authors:  Weidong Sun; Xu Yang; Hengbin Qiu; Di Zhang; Huanan Wang; Jian Huang; Degui Lin
Journal:  J Vet Med Sci       Date:  2015-07-05       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.